COMMUNIQUÉS West-GlobeNewswire

Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date
15/02/2018
BATON ROUGE, La., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), announced today that it will report results for the fourth quarter and year ended December 31, 2017 after the market closes on February [...]
Sienna Announces February Dividend
15/02/2018
MARKHAM, Ontario, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) for [...]
Solon Eiendom ASA : Notice of extraordinary general meeting
15/02/2018
(Oslo, 15 February 2018) Solon Eiendom ASA (OSE: SOLON), calls for the extraordinary general meeting to be held at the company's offices in Olav Vs gate 5, 0161, Oslo, Norway on 09 March 2018 at 10 am (CET). The notice [...]
Immunovaccine Announces Closing of $14.375 million Bought Deal Offering with Over-allotment option exercised in full
15/02/2018
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, N.S., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (“Immunovaccine” or the “Corporation”) (TSX: IMV ) (OTCQX:IMMVF), a [...]
Immunovaccine annonce la clôture d’un placement par voie de prise ferme de 14,375 millions de dollars compte tenu de l’option de surallocation intégralement exercée
15/02/2018
NE PAS DISTRIBUER À DES AGENCES DE TRANSMISSION DES ÉTATS-UNIS NI DIFFUSER AUX ÉTATS-UNIS HALIFAX, N.S., 15 févr. 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (« Immunovaccine » ou la « société ») (TSX: IMV ) (OTCQX: [...]
Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance
15/02/2018
NEW HAVEN, Conn., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ) announced today its launch of the first lung cancer treatment resistance panel specifically for the critical mutations T790M and C797S [...]
Argos Announces Issuance of Patent Covering the Foundation for Manufacturing its HIV Immunotherapy
15/02/2018
DURHAM, N.C., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]
Scythian Biosciences Announces Appointment of Professor Michael Barnes as Chief Medical Officer
15/02/2018
- Influential voice in medical cannabis policy in Europe - A leading world authority in neurological rehabilitation TORONTO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “ Company ” or “ Scythian [...]
CORRECTION - Shire Announces FDA Acceptance of sBLA for CINRYZE® for Pediatric Hereditary Angioedema Use
15/02/2018
**CORRECTION - Shire Announces FDA Acceptance of sBLA for CINRYZE ® (C1 esterase inhibitor [human]) for Pediatric Hereditary Angioedema Use FDA assigns an action date of June 20, 2018 If approved, CINRYZE will be the [...]
Optinose to Present at the 2018 RBC Capital Markets Healthcare Conference
15/02/2018
YARDLEY, Pa., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive [...]
Epilepsy Foundation Pipeline Conference to Feature Winners of the SUDEP Challenge on Identifying Biomarkers Predicting Sudden Unexpected Death in Epilepsy (SUDEP)
15/02/2018
LANDOVER, Md., Feb. 15, 2018 (GLOBE NEWSWIRE) -- The Epilepsy Foundation Pipeline Conference will feature the winners of the SUDEP Institute’s 2 nd milestone of its fourth challenge , “Developing Predictive Biomarkers [...]
UPDATE - Intra-Cellular Therapies to Present at RBC Capital Markets 2018 Global Healthcare Conference
15/02/2018
NEW YORK, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results
15/02/2018
- GEN-009 neoantigen vaccine advancing to IND filing - - Balance sheet strengthened with $55m gross proceeds from January equity financing - - Conference call today at 9 am ET - CAMBRIDGE, Mass., Feb. 15, 2018 (GLOBE [...]
Extendicare Announces February 2018 Dividend of C$0.04 per Share
15/02/2018
MARKHAM, Ontario, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018
15/02/2018
BOSTON, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Athenex Meets Enrollment Target for Oraxol Phase III Clinical Trial in Metastatic Breast Cancer
15/02/2018
BUFFALO, N.Y., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer [...]
Immunomedics to Participate in RBC Capital Markets 2018 Global Healthcare Conference
15/02/2018
MORRIS PLAINS, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that Michael Pehl, President and Chief Executive Officer, will participate in [...]
Progressive Care to Accept Bitcoin for its Pharmacy Unit
15/02/2018
MIAMI, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that its retail pharmacy will officially begin accepting Bitcoin payments. Customers [...]
Cytori Scleroderma Trial Data Presented at Systemic Sclerosis World Congress
15/02/2018
SAN DIEGO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX ) (“Cytori” or “the Company”) today presented data from the U.S. 88 patient, 19 center, randomized, double blind, placebo-controlled [...]

Pages